Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

Inclusion Criteria

• •1. Written informed consent to participate in the study;
• •2. Adult patients of either sex aged ≥ 40 years;
• •3. Patients with diagnosis of moderate to very severe COPD according to Gold Initiative for Chronic Obstructive Lung Disease (GOLD) updated 2019 (GOLD Stage 2-4);
• •4. COPD assessment test (CAT) score ≥ 10 at initiation of BDP/FF/G fixed combination;
• •5. History of \>1 moderate or severe COPD exacerbation during the previous year.
• •6. Patients in treatment with BDP/FF/G as per local clinical practice and according to Trimbow® Summary of Product Characteristics (SmPC).